HCC with portal vein tumor thrombosis: how to manage?

Abstract

Minagawa M, Makuuchi M. treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombosis. World J Gastroenterol. 2006;12(47):7561–7. CAS Article Google Scholar Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, Fong Y, et al. Hepatocellular carcinoma: consensus recommendations of the national cancer institute clinical trials planning meeting. J ClinOncol. 2010;28:3994–4005. Article Google Scholar Hatano E, Uemoto S, Yamane H, Yamamoto M, Japanese society of hepato-biliary-pancreatic surgery. Significance of hepatic resection and adjuvant hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombus in the first branch of portal vein and the main portal trunk: a project study for hepatic surgery of the Japanese society of hepato-biliary-pancreatic surgery. J HepatobiliaryPancreatSci. 2018;25:395–402. Google Scholar Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, et al. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatology. 2016;65:938–43. Article Google Scholar Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM, Chung WJ, et al. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis. ClinMolHepatol. 2016;22:160–7. Google Scholar Liu PH, Lee YH, Hsia CY, Hsu CY, Huang YH, Chiou YY, et al. Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis. Ann SurgOncol. 2014;21:1825–33. Google Scholar Chen ZH, Zhang XP, Lu YG, Li LQ, Chen MS, Wen TF, et al. Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study. HepatolInt. 2020. https://doi.org/10.1007/s12072-020-10032-2(Online ahead of print). Article Google Scholar El-Sherif O, Jiang ZG, Tapper EB, Huang KC, Zhong A, Osinusi A, et al. Baseline factors associated with improvements in decompensated cirrhosis after direct-acting antiviral therapy for hepatitis C virus infection. Gastroenterology. 2018;154:2111–21. CAS Article Google Scholar Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378–90. CAS Article Google Scholar Bruix J, Raoul JL, Sherman M, Mazzaferro V, Bolondi L, Craxi A, et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. J Hepatol. 2012;57:821–9. CAS Article Google Scholar Yamamoto Y, Ikoma H, Morimura R, Shoda K, Konishi H, Murayama Y, et al. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol. 2015;21:246–53. CAS Article Google Scholar Lau WY, Sangro B, Chen PJ, Cheng SQ, Chow P, Lee RC, et al. Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90. Oncology. 2013;84:311–8. CAS Article Google Scholar Couri T, Pillai A. Goals and targets for personalized therapy for HCC. HepatolInt. 2019;13:125–37. Google Scholar Download references Division of Transplant Surgery, JCHO Sendai Hospital, 3-16-1 Tsutsumi-machi, Aoba-ku, Sendai, 981-8501, Japan Naoki Kawagishi Division of General Medicine, Imakane Town National Health Insurance Hospital, 17-2 Azaimakane, Imakane, 049-4318, Japan Naoki Kawagishi You can also search for this author in PubMed Google Scholar Correspondence to Naoki Kawagishi. Naoki Kawagishi declares that he has no conflict of interest. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Informed consent was obtained from all patients for being included in the study. This article does not contain any studies with animal subjects. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Reprints and Permissions Kawagishi, N. HCC with portal vein tumor thrombosis: how to manage?. Hepatol Int (2020). https://doi.org/10.1007/s12072-020-10090-6 Download citation Received: 06 July 2020 Accepted: 04 September 2020 Published: 19 September 2020 DOI: https://doi.org/10.1007/s12072-020-10090-6